Provided by Tiger Trade Technology Pte. Ltd.

Phathom Pharmaceuticals

8.67
-0.7600-8.06%
Pre-market: 8.770.1039+1.20%07:21 EDT
Volume:1.11M
Turnover:9.78M
Market Cap:701.41M
PE:-6.85
High:9.32
Open:9.32
Low:8.64
Close:9.43
52wk High:18.31
52wk Low:8.21
Shares:80.90M
Float Shares:63.93M
Volume Ratio:1.17
T/O Rate:1.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2659
EPS(LYR):-3.0342
ROE:-3489.00%
ROA:-8.80%
PB:-2.04
PE(LYR):-2.86

Loading ...

Phathom Pharmaceuticals Initiated at Market Perform by Leerink Partners

Dow Jones
·
Yesterday

Leerink Partners Initiates Coverage on Phathom Pharmaceuticals With Market Perform, $10 PT

MT Newswires Live
·
Yesterday

Phathom Pharmaceuticals initiated with a Market Perform at Leerink

TIPRANKS
·
Yesterday

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 01

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 17

Phathom Pharmaceuticals’ Earnings Call Signals Profitable Growth

TIPRANKS
·
Aug 16

Phathom Pharmaceuticals (PHAT) Stock Slides Despite Cash Profit Breakthrough

Simply Wall St.
·
Aug 01

Phathom Pharmaceuticals is Maintained at Buy by Needham

Dow Jones
·
Jul 31

Phathom Pharmaceuticals price target lowered to $22 from $28 at Needham

TIPRANKS
·
Jul 31

Phathom Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Phathom Pharmaceuticals Down over 19%, on Track for Largest Percent Decrease Since May 2025

Dow Jones
·
Jul 31

Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth

Reuters
·
Jul 30

Phathom Q2 GAAP Net Loss Narrows to $17.6 Million from Year-ago; Revenue Rises 88% to $74.3 Million

Reuters
·
Jul 30

Phathom Pharmaceuticals Q2 Sales $74.300M Beat $72.789M Estimate

Benzinga Earnings
·
Jul 30

Phathom Pharmaceuticals Outlook FY Revenue USD 310-325 Million VS. Ibes Estimate USD 332.2 Million

THOMSON REUTERS
·
Jul 30

Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million

THOMSON REUTERS
·
Jul 30

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Jul 30

Phathom Pharma Schedules Second-quarter Earnings Webcast

Reuters
·
Jul 20

Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026

GlobeNewswire
·
Jul 20

Analysts Conflicted on These Healthcare Names: Phathom Pharmaceuticals (PHAT) and Elicio Therapeutics (ELTX)

TIPRANKS
·
Jun 25